SLDB
Solid Biosciences LLC
8.90$
+4.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -0.2% | -44.3% | +277.7% | -67.2% | +20.5% | -16.6% | -5.2% | -2.6% | +24.2% | -15.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.5% | +22.1% | +3.1% | +40.4% | +12.6% | +0.5% | +4.9% | +19.9% | -1.9% | +21.0% | -4.1% | – | |
| – | +6.2% | +17.3% | +4.2% | -5.7% | +16.2% | +0.1% | +1.5% | -0.9% | +22.5% | -0.9% | +17.5% | – | |
| – | -3.7% | +19.2% | +4.7% | +26.6% | +13.4% | -0.6% | +4.2% | +16.3% | +2.8% | +15.2% | +0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,749.1% | -95.2% | -7.4% | -6.8% | -8.5% | -9.3% | -11.8% | +460.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -93.8% | -535.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.